A live, case-based webinar held on June 2, 2026 looked at when and how patients with advanced pulmonary disease should be referred for lung transplant evaluation. The expert faculty walked through evidence-based referral criteria, disease-specific considerations, and complex scenarios — including interstitial lung disease, pulmonary arterial hypertension, and critically ill patients in the Intensive Care Unit (ICU). A key theme throughout was the importance of early referral, giving enough time for patient education, multidisciplinary evaluation, management of comorbidities, and shared decision-making.
Learning Objectives
- Apply evidence-based referral criteria to real-world cases to support early lung transplant referral decisions.
- Use an evidence-based approach to complex cases involving comorbidities to determine when referral remains appropriate despite perceived contraindications.
- Analyze clinical scenarios involving critically ill patients with advanced pulmonary disease to determine when lung transplant referral is appropriate despite clinical instability.
- This activity was sponsored by United Therapeutics.
You can watch entire webinar at this link